Havana, Dec 11 (Prensa Latina) The Business Group of the Biotechnology and Pharmaceutical Industries of Cuba (BioCubaFarma) maintains on its agenda the execution of 14 prioritized research projects linked, mainly, to cancer immunotherapy, to the treatment of neurological, autoimmune, degenerative diseases and of the cardiovascular system, as well as new immunogens.